|
|
Post by dreamboatcruise on Oct 3, 2017 15:03:10 GMT -5
Just keep saying negative things please  . And don't leave. You may be just what we need. Yes, brewguy i am right there with you (deep in red still) but your appearance on this board has coincided with a nice run, so thanks for showing up and please stay. You have a right to your perspective even if negative, it's been a tough road. You're just calling it like you see it, same as DBC and others who sometimes unfairly get questioned about being a short. The way i see it, if MNKD can turn this ship around and get folks like you (and me too for that matter) feeling bullish, then we really will have something to celebrate. There are plenty on this board who seem to me irrationally positive all the time, but it is my hope to one day tell them, "my bad, you were right all along!" Surely not here... I'm shocked   But I'm going to be looking for that apology from you when finally all the things they've told us about come true... when it is revealed that Merck, Amgen, Medtronic, Apple and Google all in a bidding war to acquire MNKD and Mike putting them off only because he's busy personally piloting the ship sailing to the UAE full of Afrezza.  |
|
|
|
Post by mytakeonit on Oct 3, 2017 15:19:33 GMT -5
New Flash ... cretin11 finally says ... "my bad, you were right all along!"
Major New Flash ... MNKD's funding $$$ goes up $13M in one day !!!
|
|
|
|
Post by cretin11 on Oct 3, 2017 15:30:23 GMT -5
New Flash ... cretin11 finally says ... "my bad, you were right all along!" Major New Flash ... MNKD's funding $$$ goes up $13M in one day !!! And to clarify, I'm not saying that yet! Once share price matches my highest buy-in point, THEN i will say it! And buy a round for all you characters.  |
|
|
|
Post by dreamboatcruise on Oct 3, 2017 15:51:57 GMT -5
New Flash ... cretin11 finally says ... "my bad, you were right all along!" Major New Flash ... MNKD's funding $$$ goes up $13M in one day !!! And to clarify, I'm not saying that yet! Once share price matches my highest buy-in point, THEN i will say it! And buy a round for all you characters. Do I have to engage in some pumping hype in order to get in on this free booze offer? I predict the stock is going to $1000 I like really good scotch. |
|
|
|
Post by brewguy on Oct 3, 2017 15:56:33 GMT -5
Yes, brewguy i am right there with you (deep in red still) but your appearance on this board has coincided with a nice run, so thanks for showing up and please stay. You have a right to your perspective even if negative, it's been a tough road. You're just calling it like you see it, same as DBC and others who sometimes unfairly get questioned about being a short. The way i see it, if MNKD can turn this ship around and get folks like you (and me too for that matter) feeling bullish, then we really will have something to celebrate. There are plenty on this board who seem to me irrationally positive all the time, but it is my hope to one day tell them, "my bad, you were right all along!" The stock price is up more than 400 percent in the last five months, so that sounds like the ship turning around to me. I credit Mike with the turnaround (after he inherited an almost impossible situation caused by the Sanofi sandbagging). yes we can read the chart. I don't deny it's up a lot but I am cautious to celebrate anything yet. In my eyes, this run doesn't have much behind it. I hope I'm wrong but this can fall just as fast as it rose if we don't get any significant news soon.. We've seen MNKD lose its gains almost like clockwork on every run up. A lot of day and momentum traders have jumped in here who couldn't care less about the science behind the company. They will jump ship as soon as the tide turns with tight stop losses. My ID may be new here but I am very experienced at investing. I would be very very cautious to assume this run will hold without any positive news very soon. On top of that, 20 million share may be dumped on to the market with the possibility of more. How do you think this will affect the stock price? I'm a realist here so please forgive me if sound less than ideal from your usual hyped up "yes men". |
|
|
|
Post by cretin11 on Oct 3, 2017 16:02:20 GMT -5
And to clarify, I'm not saying that yet! Once share price matches my highest buy-in point, THEN i will say it! And buy a round for all you characters. Do I have to engage in some pumping hype in order to get in on this free booze offer? I predict the stock is going to $1000 I like really good scotch. So do i, DBC, so no irrational pumping needed for you to get the free booze offer. I've always wanted to try an Ardbeg 1974... |
|
|
|
Post by peppy on Oct 3, 2017 16:06:17 GMT -5
The stock price is up more than 400 percent in the last five months, so that sounds like the ship turning around to me. I credit Mike with the turnaround (after he inherited an almost impossible situation caused by the Sanofi sandbagging). yes we can read the chart. I don't deny it's up a lot but I am cautious to celebrate anything yet. In my eyes, this run doesn't have much behind it. I hope I'm wrong but this can fall just as fast as it rose if we don't get any significant news soon.. We've seen MNKD lose its gains almost like clockwork on every run up. A lot of day and momentum traders have jumped in here who couldn't care less about the science behind the company. They will jump ship as soon as the tide turns with tight stop losses. My ID may be new here but I am very experienced at investing. I would be very very cautious to assume this run will hold without any positive news very soon. On top of that, 20 million share may be dumped on to the market with the possibility of more. How do you think this will affect the stock price? I'm a realist here so please forgive me if sound less than ideal from your usual hyped up "yes men". Quote: We've seen MNKD lose its gains almost like clockwork on every run up.
Have any idea when the clock will run out? Have you figured out how long we have?
On this monthly chart, we are only three days into this new month, two days of trading. At some level does this look like it could be a mirror image going the opposite way?
|
|
|
|
Post by n8 on Oct 3, 2017 16:07:09 GMT -5
Do I have to engage in some pumping hype in order to get in on this free booze offer? I predict the stock is going to $1000 I like really good scotch. So do i, DBC, so no irrational pumping needed for you to get the free booze offer. I've always wanted to try an Ardbeg 1974... Ill drink piss from a boot if this finally gets to the people that need it and saves countless lives and improves quality of life for millions....... |
|
|
|
Post by dreamboatcruise on Oct 3, 2017 16:17:08 GMT -5
The stock price is up more than 400 percent in the last five months, so that sounds like the ship turning around to me. I credit Mike with the turnaround (after he inherited an almost impossible situation caused by the Sanofi sandbagging). yes we can read the chart. I don't deny it's up a lot but I am cautious to celebrate anything yet. In my eyes, this run doesn't have much behind it. I hope I'm wrong but this can fall just as fast as it rose if we don't get any significant news soon.. We've seen MNKD lose its gains almost like clockwork on every run up. A lot of day and momentum traders have jumped in here who couldn't care less about the science behind the company. They will jump ship as soon as the tide turns with tight stop losses. My ID may be new here but I am very experienced at investing. I would be very very cautious to assume this run will hold without any positive news very soon. On top of that, 20 million share may be dumped on to the market with the possibility of more. How do you think this will affect the stock price? I'm a realist here so please forgive me if sound less than ideal from your usual hyped up "yes men". We did 13 million in volume today on a strong up day. Sentiment right now seems to be such that even 20 million shares could be fed (not dumped) into market. Question is whether to sustain this sentiment we need some spectacular event, or whether slow steady progress keeps bringing new investors and providing support for the ATM. What if we get another international deal but without upfront, we get some small progress payment from RLS which at least proves they're alive, we start seeing 2018 formularies improving coverage, treprostinil is filed, time in range study completes and looks positive and we learn that MNKD is keeping up with the cash burn by slowly tapping the ATM... all the while scripts continue to grow? You can correctly cite that gains in the past have quickly reversed, but I think there is a difference that we now have a backdrop of a real turn around taking shape. Lest my detractors think I've gone soft (I'd hate to have everyone liking me here)... caveat investor... this is still a very risky stock to own. Even if you want to give the benefit of the doubt that Mike has everything in hand, we're probably just one big market correction away from imploding. |
|
|
|
Post by brewguy on Oct 3, 2017 16:25:42 GMT -5
nylefty yes we can read the chart. I don't deny it's up a lot but I am cautious to celebrate anything yet. In my eyes, this run doesn't have much behind it. I hope I'm wrong but this can fall just as fast as it rose if we don't get any significant news soon.. We've seen MNKD lose its gains almost like clockwork on every run up. A lot of day and momentum traders have jumped in here who couldn't care less about the science behind the company. They will jump ship as soon as the tide turns with tight stop losses. My ID may be new here but I am very experienced at investing. I would be very very cautious to assume this run will hold without any positive news very soon. On top of that, 20 million share may be dumped on to the market with the possibility of more. How do you think this will affect the stock price? I'm a realist here so please forgive me if sound less than ideal from your usual hyped up "yes men". We did 13 million in volume today on a strong up day. Sentiment right now seems to be such that even 20 million shares could be fed (not dumped) into market. Question is whether to sustain this sentiment we need some spectacular event, or whether slow steady progress keeps bringing new investors and providing support for the ATM. What if we get another international deal but without upfront, we get some small progress payment from RLS which at least proves they're alive, we start seeing 2018 formularies improving coverage, treprostinil is filed and we learn that MNKD is keeping up with the cash burn by slowly tapping the ATM... all the while scripts continue to grow? You can correctly cite that gains in the past have quickly reversed, but I think there is a difference that we now have a backdrop of a real turn around taking shape. Lest my detractors think I've gone soft (I'd hate to have everyone liking me here)... caveat investor... this is still a very risky stock to own. Even if you want to give the benefit of the doubt that Mike has everything in hand, we're probably just one big market correction away from imploding. @dreamboat I guess everyone can now hate me instead 😂. I just don't see any great reason for this to run. Has much actually changed? We are still flirting with only 400rx per week. Label change didn't change much IMO. Cash continues to be a major issue. I'll eat my words but I'm confident this pop will not hold. |
|
|
|
Post by goyocafe on Oct 3, 2017 16:47:13 GMT -5
We did 13 million in volume today on a strong up day. Sentiment right now seems to be such that even 20 million shares could be fed (not dumped) into market. Question is whether to sustain this sentiment we need some spectacular event, or whether slow steady progress keeps bringing new investors and providing support for the ATM. What if we get another international deal but without upfront, we get some small progress payment from RLS which at least proves they're alive, we start seeing 2018 formularies improving coverage, treprostinil is filed and we learn that MNKD is keeping up with the cash burn by slowly tapping the ATM... all the while scripts continue to grow? You can correctly cite that gains in the past have quickly reversed, but I think there is a difference that we now have a backdrop of a real turn around taking shape. Lest my detractors think I've gone soft (I'd hate to have everyone liking me here)... caveat investor... this is still a very risky stock to own. Even if you want to give the benefit of the doubt that Mike has everything in hand, we're probably just one big market correction away from imploding. @dreamboat I guess everyone can now hate me instead 😂. I just don't see any great reason for this to run. Has much actually changed? We are still flirting with only 400rx per week. Label change didn't change much IMO. Cash continues to be a major issue. I'll eat my words but I'm confident this pop will not hold. I think you may be underestimating the value the label change has with regard to future sales. And future sales is what drives a stock price. JMHO |
|
|
|
Post by dreamboatcruise on Oct 3, 2017 16:53:20 GMT -5
We did 13 million in volume today on a strong up day. Sentiment right now seems to be such that even 20 million shares could be fed (not dumped) into market. Question is whether to sustain this sentiment we need some spectacular event, or whether slow steady progress keeps bringing new investors and providing support for the ATM. What if we get another international deal but without upfront, we get some small progress payment from RLS which at least proves they're alive, we start seeing 2018 formularies improving coverage, treprostinil is filed and we learn that MNKD is keeping up with the cash burn by slowly tapping the ATM... all the while scripts continue to grow? You can correctly cite that gains in the past have quickly reversed, but I think there is a difference that we now have a backdrop of a real turn around taking shape. Lest my detractors think I've gone soft (I'd hate to have everyone liking me here)... caveat investor... this is still a very risky stock to own. Even if you want to give the benefit of the doubt that Mike has everything in hand, we're probably just one big market correction away from imploding. @dreamboat I guess everyone can now hate me instead 😂. I just don't see any great reason for this to run. Has much actually changed? We are still flirting with only 400rx per week. Label change didn't change much IMO. Cash continues to be a major issue. I'll eat my words but I'm confident this pop will not hold. I've printed your post out and will save it for you to eat with the Ardbeg. Yum, a fine pairing, the pulpiness of the paper with the smokey of the scotch... though, I'll be having steak tartare. Well, it is hard to see a reason for this magnitude of run, unless... you buy into the idea that the magnitude of the sell off was unwarranted. In my opinion there was a significant risk of bankruptcy priced in. Even if we're in for painful dilution, the lows we hit would be unwarranted, IMO. For awhile, it was looking like dilution might not even be possible to buy time... and hence likelihood of bankruptcy weighed much heavier on share price. When risk of bankruptcy is part of what was factored into price, change of sentiment can make a real difference. |
|
|
|
Post by mnholdem on Oct 3, 2017 17:09:47 GMT -5
MannKind has outperformed the mighty Sanofi in sales revenue for Afrezza with a subpar label and a fraction of the sales force. Sanofi could have (perhaps should have) fixed the label inadequacies but chose not to invest in the future and returned Afrezza to MannKind. CEO Brandicourt probably never got over his $2 billion debacle with Exubura while he was with Pfizer. Instead of fixing the problem he ran away from it.
Today, the label upgrade finally gives the MannKind sales force something they can use to convince prescribers that Afrezza stands apart from all other insulin. The new label also has ramifications for international sales, since many countries expedite FDA-approved drugs without requiring exhaustive testing of their own. Only two countries in the world permit direct to consumer advertising, so it's the government agencies and doctors that you must convince. They are the people that supply their countries with cost-effective drugs and prescribe them to their patients with diabetes.
Perhaps Wall Street is once again seeing the potential of Afrezza Inhaled Insulin that they once saw with a MannKind/Sanofi agreement...and they're ready to start buying MNKD stock once again.
Diabetes remains a global epidemic that isn't going away and patients, doctors and governments are looking for answers. |
|
|
|
Post by ghochr on Oct 3, 2017 17:11:10 GMT -5
nylefty yes we can read the chart. I don't deny it's up a lot but I am cautious to celebrate anything yet. In my eyes, this run doesn't have much behind it. I hope I'm wrong but this can fall just as fast as it rose if we don't get any significant news soon.. We've seen MNKD lose its gains almost like clockwork on every run up. A lot of day and momentum traders have jumped in here who couldn't care less about the science behind the company. They will jump ship as soon as the tide turns with tight stop losses. My ID may be new here but I am very experienced at investing. I would be very very cautious to assume this run will hold without any positive news very soon. On top of that, 20 million share may be dumped on to the market with the possibility of more. How do you think this will affect the stock price? I'm a realist here so please forgive me if sound less than ideal from your usual hyped up "yes men". We did 13 million in volume today on a strong up day. Sentiment right now seems to be such that even 20 million shares could be fed (not dumped) into market. Question is whether to sustain this sentiment we need some spectacular event, or whether slow steady progress keeps bringing new investors and providing support for the ATM. What if we get another international deal but without upfront, we get some small progress payment from RLS which at least proves they're alive, we start seeing 2018 formularies improving coverage, treprostinil is filed, time in range study completes and looks positive and we learn that MNKD is keeping up with the cash burn by slowly tapping the ATM... all the while scripts continue to grow? You can correctly cite that gains in the past have quickly reversed, but I think there is a difference that we now have a backdrop of a real turn around taking shape. Lest my detractors think I've gone soft (I'd hate to have everyone liking me here)... caveat investor... this is still a very risky stock to own. Even if you want to give the benefit of the doubt that Mike has everything in hand, we're probably just one big market correction away from imploding. 13 million in the hopes that there is something around the corner. But once MNKD starts using ATM sentiment will change in a moment. |
|
|
|
Post by straightly on Oct 3, 2017 17:21:28 GMT -5
nylefty yes we can read the chart. I don't deny it's up a lot but I am cautious to celebrate anything yet. In my eyes, this run doesn't have much behind it. I hope I'm wrong but this can fall just as fast as it rose if we don't get any significant news soon.. We've seen MNKD lose its gains almost like clockwork on every run up. A lot of day and momentum traders have jumped in here who couldn't care less about the science behind the company. They will jump ship as soon as the tide turns with tight stop losses. My ID may be new here but I am very experienced at investing. I would be very very cautious to assume this run will hold without any positive news very soon. On top of that, 20 million share may be dumped on to the market with the possibility of more. How do you think this will affect the stock price? I'm a realist here so please forgive me if sound less than ideal from your usual hyped up "yes men". We did 13 million in volume today on a strong up day. Sentiment right now seems to be such that even 20 million shares could be fed (not dumped) into market. Question is whether to sustain this sentiment we need some spectacular event, or whether slow steady progress keeps bringing new investors and providing support for the ATM. What if we get another international deal but without upfront, we get some small progress payment from RLS which at least proves they're alive, we start seeing 2018 formularies improving coverage, treprostinil is filed, time in range study completes and looks positive and we learn that MNKD is keeping up with the cash burn by slowly tapping the ATM... all the while scripts continue to grow? You can correctly cite that gains in the past have quickly reversed, but I think there is a difference that we now have a backdrop of a real turn around taking shape. Lest my detractors think I've gone soft (I'd hate to have everyone liking me here)... caveat investor... this is still a very risky stock to own. Even if you want to give the benefit of the doubt that Mike has everything in hand, we're probably just one big market correction away from imploding. What is our ATM? How does it work? I thought it was a right we obtained to sell commons to a third party, not to the public. Please correct me if I am wrong. |
|
. And don't leave. You may be just what we need.
